摘要
色素沉着是医学和美学中的重要问题。暗区或皮肤上的黑斑由过量的皮肤色素沉积所导致。一些脱色剂,如麴酸、熊果苷、芦荟苦素、鞣花酸、白藜芦醇、杜鹃花酸、烟酰胺、维甲酸、乙醇酸,乳酸,柠檬酸,已被确定和应用于外用药物或化妆品制剂来治疗色素沉着。然而,这些化合物的特点是有效性不足并且会产生不良反应。因此,仍然有必要寻找新的活性物质。本文总结了寻找新的黑色素生成抑制剂的方法。他们按照特定的方法分别在硅片上、在体外和体内进行实验。在硅片的研究包括与酪氨酸酶和双铜配合物模型计算研究。体外法是基于测试使用酪氨酸酶(黑色素生物合成的关键酶),细胞培养,细胞共同培养时,色素的人皮肤替代物或比基尼链霉菌模型。在体内研究以斑马鱼,啮齿类动物或人体为模型。本文介绍了实验室程序的案例,专注于用于评价被测试化合物作用机制的不同模型。还讨论了这些方法潜在的局限性,以及对筛选黑素合成抑制剂未来的展望。
关键词: 脱色剂,色素沉着,硅片,体外,体内,黑色素,黑色素抑制剂,酪氨酸酶
Current Medicinal Chemistry
Title:Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds
Volume: 23 Issue: 31
Author(s): Agnieszka Gunia-Krzyżak, Justyna Popiol, Henryk Marona
Affiliation:
关键词: 脱色剂,色素沉着,硅片,体外,体内,黑色素,黑色素抑制剂,酪氨酸酶
摘要: Hyperpigmentation disorders constitute important medical and aesthetical conditions. Dark areas or dark spots on the skin result from inappropriate amount and/or deposition of skin pigments - melanins. Several depigmenting agents, such as kojic acid, arbutin, aloesin, ellagic acid, resveratrol, azelaic acid, niacinamide, tretinoin, glycolic acid, lactic acid, and citric acid, have already been identified and are used in topical drugs or cosmetic formulations for the treatment of hyperpigmentations. However, these compounds are characterized by insufficient effectiveness and multiple adverse effects. As a result, there is still a need for searching for new active substances. The current paper summarizes strategies for searching for novel melanogenesis inhibitors. In the review, they are divided according to approach, into in silico, in vitro and in vivo experiments. In silico research includes computational studies with models of tyrosinase and di-copper complexes. The in vitro approach is based on tests using tyrosinase (a key enzyme in melanin biosynthesis), cell cultures, cell co-cultures, pigmented human skin equivalents or Streptomyces bikiniensis model. In vivo studies involve zebrafish, rodents or humans. Examples of protocols and laboratory procedures are presented, with a focus on utilization of various models for evaluation of mechanisms of action of tested compounds. The potential limitations of the methods are also discussed, together with future perspectives in the field of searching for melanogenesis inhibitors.
Export Options
About this article
Cite this article as:
Agnieszka Gunia-Krzyżak, Justyna Popiol, Henryk Marona , Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds, Current Medicinal Chemistry 2016; 23 (31) . https://dx.doi.org/10.2174/0929867323666160627094938
DOI https://dx.doi.org/10.2174/0929867323666160627094938 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anabolic Androgenic Steroids Abuse and Liver Toxicity
Mini-Reviews in Medicinal Chemistry Human Apurinic/Apyrimidinic Endonuclease (APE1): An Emerging Anti-Cancer Biomarker
Recent Patents on Biomarkers Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Studies of NVP-BEZ235 in Melanoma
Current Cancer Drug Targets Phenolic Compounds as Nutraceuticals or Functional Food Ingredients
Current Pharmaceutical Design DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry Critical Issues in Delivery of RNAi Therapeutics In Vivo
Current Pharmaceutical Biotechnology Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy
Current Drug Targets Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment
Current Signal Transduction Therapy Therapeutic Perspectives on Pancreatic Cancer
Current Cancer Drug Targets The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology In Vivo Animal Models for Investigating Potential CYP3A- and Pgp-Mediated Drug-Drug Interactions
Current Drug Metabolism Experimental Benefits of Sex Hormones on Vascular Function and the Outcome of Hormone Therapy in Cardiovascular Disease
Current Cardiology Reviews Chemical Instability Determines the Biological Action of the Artemisinins
Current Medicinal Chemistry Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment
Current Cancer Therapy Reviews Replicative Senescence: The Final Stage of Memory T Cell Differentiation?
Current HIV Research Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Current Molecular Medicine Polysaccharide based Copolymers as Supramolecular Systems in Biomedical Applications
Current Drug Targets Interaction of Anthocyanins with Drug-metabolizing and Antioxidant Enzymes
Current Medicinal Chemistry